Tech Company Financing Transactions
CardioDx Funding Round
CardioDx, based in Redwood City, secured $60 million from Acadia Woods Ventures, Artiman Ventures and Asset Management Ventures.
Transaction Overview
Company Name
Announced On
3/31/2011
Transaction Type
Venture Equity
Amount
$60,000,000
Round
Undisclosed
Investors
Proceeds Purpose
Funding will be used to expand reimbursement coverage in the United States for Corus� CAD, the company's blood-based gene expression test for obstructive coronary artery disease, and to continue development of future products in the field of cardiovascular genomic diagnostics.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
600 Saginaw Dr.
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Website
Email Address
Overview
CardioDx, a pioneer in the field of cardiovascular genomic diagnostics, is committed to improving the quality of care for patients with cardiovascular disease through the research, development, and validation of clinically important genomic tests.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Khush Mehta
Chief Financial Officer
Timothy Henn
Chief Medical Officer
Mark Monane
VP - Bus. Development
Susan Daniels
VP - Bus. Development
David Levison
VP - R & D
James Wingrove
VP - Sales
Duane Williams
Browse more venture capital transactions:
Prev: 3/31/2011: Samara Innovations venture capital transaction
Next: 3/31/2011: Crystal IS venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on tech company VC transactions. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs